Publication | Open Access

Arylboronate prodrugs of doxorubicin as promising chemotherapy for pancreatic cancer

Medicinal ChemistryOncologyPancreatic CancerPolymer-drug ConjugateMedicineArylboronate ProdrugsPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchDrug Discovery